LJL BioSystems - About the company
LJL BioSystems is an acquired company based in Sunnyvale (United States), founded in 1988. It operates as a Limited information available. The company has 782 active competitors, including 52 funded and 47 that have exited. Its top competitors include companies like Simulations Plus, Alloy Therapeutics and Manifold Bio.
Key Metrics
Founded Year
1988
Location
Sunnyvale, United States
Stage
Acquired
Investors
Ranked
122nd among 782 active competitors
Similar Companies
Exit Details
Acquired by Molecular Devices (Aug 30, 2000)
Legal entities associated with LJL BioSystems
LJL BioSystems is associated with 1 legal entity given below:
Legal Entity Name | Date of Incorporation | Revenue | Latest Employee Count | Documents |
|---|---|---|---|---|
LJL Biosystems Inc CIN: 77-0360183 , United States, Active | - | - | - |
LJL BioSystems's acquisition details
LJL BioSystems got acquired by Molecular Devices on Aug 30, 2000. It was facilitated by Mercator Capital and Broadoak Capital Partners.
Click here to take a look at LJL BioSystems's acquisition in detail
Sign up to download LJL BioSystems' company profile
LJL BioSystems's funding and investors
LJL BioSystems is a funded company. LJL BioSystems has 2 institutional investors.
View details of LJL BioSystems's funding rounds and investors
Access Tracxn on any website
Install Tracxn ExtensionOur Google Chrome extension lets you view company details while browsing their websites
LJL BioSystems's Competitors and alternates
Top competitors of LJL BioSystems include Simulations Plus, Alloy Therapeutics and Manifold Bio. Here is the list of Top 10 competitors of LJL BioSystems, ranked by Tracxn score:
Get insights and benchmarks for competitors of 2M+ companies! Sign up today!
Rank | Company Details | Short Description | Total Funding | Investors | Tracxn Score |
|---|---|---|---|---|---|
1st | Simulations Plus 1996, Lancaster (United States), Public | Developer of modeling and simulation software and consulting services provider | - | 65/100 | |
2nd | Alloy Therapeutics 2017, Lexington (United States), Series D | Provider of drug discovery services | $117M | 63/100 | |
3rd | Manifold Bio 2018, United States, Series A | Developer of tissue-targeted therapeutics using in vivo screening and AI design | $78.2M | 61/100 | |
4th | Maiva Pharma 1996, Hosur (India), Late Stage | Manufacturer of sterile injectables | $125M | 61/100 | |
5th | Biotechnology research company developing biological drugs | $160M | 56/100 | ||
6th | Biocom California 1995, San Diego (United States), Acquired | CRO focused on drug discovery & development for multiple therapeutic areas | - | - | 55/100 |
7th | Service to develop health products aiming to diagnose, prevent, delay the progression or treat hearing loss and tinnitus | $42.3M | 53/100 | ||
8th | Viva Biotech 2006, Shanghai (China), Public | Research services focused on drug discovery and development | - | 51/100 | |
9th | Superluminal Medicines 2022, Boston (United States), Series A | Generative biological and chemical company focused on drug discovery | $158M | 50/100 | |
10th | Syenex 2022, Chicago (United States), Series B | Developer of cell-specific delivery systems and programmable cell engineering payloads | $13.7M | 50/100 | |
122nd | ![]() LJL BioSystems 1988, Sunnyvale (United States), Acquired | Limited information available | - | 25/100 |
Looking for more details on LJL BioSystems's competitors? Click here to see the top ones
LJL BioSystems's Investments and acquisitions
LJL BioSystems has made no investments or acquisitions yet.
Are you a Founder ?
FAQs about LJL BioSystems
Explore our recently published companies
- Answers to ACS - Chicago based, 2013 founded, Unfunded company
- Antivirus Americas - Pembroke Pines based, 2013 founded, Unfunded company
- Antikeo - France based, 2020 founded, Unfunded company
- WinField United - Austin based, 2016 founded, Unfunded company
- Anderson Business Products - Minneapolis based, 1983 founded, Unfunded company
- Amy Green Cleaning - Sautee Nacoochee based, 2001 founded, Unfunded company
